Related Experiment Videos
Replacement of Ahmed aqueous drainage devices in eyes with device-related complications
Michael Smith1, Yvonne M Buys, Graham E Trope
1Department of Ophthalmology and Visual Sciences, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. mic.smith@utoronto.ca
Insights
Removing and replacing Ahmed aqueous drainage devices (ADDs) for complications effectively resolves issues and controls intraocular pressure (IOP). This surgical approach offers a viable solution for managing glaucoma device-related problems.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Medical Devices
Background:
- Ahmed aqueous drainage devices (ADDs) are used to manage glaucoma.
- Device-associated complications can necessitate removal of the ADD.
Purpose of the Study:
- To evaluate the outcomes of removing and simultaneously replacing Ahmed aqueous drainage devices (ADDs) when complications arise.
Main Methods:
- A noncomparative, retrospective case series was conducted.
- Six patients who required ADD removal for complications were identified.
- The removed ADDs were replaced with new Ahmed ADDs in a different quadrant during the same surgery.
Main Results:
- Complications leading to removal included chronic uveitis, plate exposure, and tube exposure.
- All preoperative complications resolved post-surgery.
- Intraocular pressure (IOP) was effectively controlled in 66.6% of cases at final follow-up.
- Mean IOP decreased from 16.0 mm Hg preoperatively to 11.0 mm Hg at final follow-up.
- The mean number of glaucoma medications decreased post-surgery.
Conclusions:
- Simultaneous removal and replacement of Ahmed ADDs in a different quadrant is an effective strategy for managing device-related complications.
- This procedure helps resolve complications and maintain adequate intraocular pressure control in glaucoma patients.
Purpose:
To examine the results of removal and simultaneous replacement of Ahmed aqueous drainage devices (ADDs), which require removal due to complications.
Methods:
Noncomparative retrospective case series of 6 patients.
Results:
For the period from January 1999 to December 2007, 325 Ahmed ADD insertions were performed in 272 patients. From this, we identified 6 patients (1.8%) who underwent removal of an ADD for device-associated complications. All had replacement of the Ahmed ADD in a different quadrant at the same surgery. The mean time interval from the original valve insertion was 31.2 months (median, 32.5; range, 3 to 67 mo). The indication for tube removal was chronic uveitis in 3 patients, plate exposure in 2 patients, and tube exposure in 1 patient. We examined the results at 12 months postsimultaneous removal and replacement of the ADD and at final follow-up (median, 25 mo; range, 13 to 52 mo). The preoperative complications resolved in all cases, with the inflammation settling postoperatively in the patients with preoperative uveitis and no patients developing tube or plate exposure at last follow-up. The mean preoperative intraocular pressure (IOP) was 16.0 mm Hg (median, 15.0; range, 9 to 29 mm Hg). At 12 months and final review, the mean IOP was 10.8 mm Hg (median, 10.0; range, 1 to 24 mm Hg) and 11.0 mm Hg (median, 10.0; range, 3 to 24 mm Hg), respectively. The mean number of glaucoma medications preoperatively was 2.8 (median, 3.5; range, 0 to 5). This was reduced to 1.7 (median, 1.5; range, 0 to 4) at 12 months and 2.2 (median, 1.5; range, 0 to 5) at final follow-up. Of the 6 cases in this series, 4 (66.6%) were considered to have adequate IOP control postoperatively. One patient developed postoperative hypotony, with an IOP of 4 mm Hg and reduced vision due to hypotony maculopathy. This patient declined further surgical intervention. One patient had a preoperative IOP of 29 mm Hg on 4 drops and acetazolamide 250 mg b.i.d. At 14 months postsurgery, IOP was 24 mm Hg on 4 drops and the patient underwent insertion of a second ADD. At last follow-up 14 months later, IOP was 10 mm Hg on 4 drops. There were no other significant intraoperative or postoperative complications in this series.
Conclusions:
In patients who require removal of Ahmed ADDs due to complications, removal of the offending ADD and replacement in another quadrant is effective in both resolving the complications and maintaining IOP control.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...